Project Description

CEO: Tyler Binney

Sector: Medtech, Orthopaedics
Location: Minneapolis, Minnesota, US
Investment Stage: Growth
Investment Status: Current
Year Invested: 2020

Relievant Medsystems

Relievant Medsystems has developed Intracept®, an outpatient, minimally invasive procedure for treating patients with vertebrogenic chronic lower back pain (CLBP). Over five millions Americans experience vertebrogenic CLBP, many of whom do not achieve lasting results after years of cycling through various courses of care. Intracept has shown improvements in both pain and function through two Level I randomised controlled trials and long-term,  five-year outcomes data.

See Relievant Medsystems related news here

Back to all companies

Endeavour Vision
Board Member

Alexander Schmitz

Endeavour Vision
Deal Team

Robert O'Holla

Robert O’Holla

Damien Tappy

Damien Tappy

Rob Barmann